```html

Neurasthenia – A Comprehensive Medical Guide

Overview

Neurasthenia is a historic term that describes a cluster of symptoms related to chronic fatigue, weakness, and a feeling of “nervous exhaustion.” While the diagnosis has largely fallen out of use in Western medicine, it remains in the International Classification of Diseases‑10 (ICD‑10) and is still reported in some Asian countries, particularly China, Japan, and Korea. Contemporary clinicians often interpret neurasthenia as a manifestation of functional somatic disorders, such as chronic fatigue syndrome (CFS), generalized anxiety disorder, or major depressive disorder.

**Who is affected?**
Neurasthenia traditionally affected middle‑aged adults, especially men in the early 20th century industrial workforce. Modern epidemiologic data from East Asian studies suggest a higher prevalence among women (≈ 2–4 % of the adult population) and among individuals with high occupational stress, low social support, or a history of trauma.

**Prevalence**
- In a 2021 Chinese community‑based survey of 12,000 adults, 3.8 % met ICD‑10 criteria for neurasthenia.<sup>[1]</sup>
- In a Japanese primary‑care cohort, the condition accounted for ~5 % of all functional somatic diagnoses.<sup>[2]</sup>

Symptoms

Symptoms are usually diffuse and persistent (≥ 6 months). The list below reflects the ICD‑10 description and common clinical observations.

Core symptoms

• Fatigue or weakness that is not relieved by rest.
• Headaches, often dull and located frontally.
• Sleep disturbances – difficulty falling asleep, non‑restorative sleep, or early awakening.
• Difficulty concentrating (often described as “brain fog”).
• Irritability or low mood without a clear depressive episode.

Associated physical complaints

• Muscle pain or tension, especially in the neck and shoulders.
• Palpitations or a sensation of “racing heart.”
• Chest discomfort not linked to cardiac disease.
• Gastrointestinal symptoms (e.g., nausea, dyspepsia).
• Generalized numbness or “pins‑and‑needles” sensations.

Psychological & behavioral signs

• Excessive worry about health (health anxiety).
• Avoidance of work or social activities due to perceived lack of stamina.
• Dependency on caffeine, stimulants, or over‑the‑counter analgesics.

Causes and Risk Factors

Neurasthenia is considered a **multifactorial functional disorder**. No single organic pathology explains the whole picture, but several contributors have been identified.

Possible biological contributors

• Altered hypothalamic‑pituitary‑adrenal (HPA) axis function leading to impaired stress response.<sup>[3]</sup>
• Neurotransmitter imbalances (low serotonin, dopamine dysregulation).
• Chronic low‑grade inflammation – elevated cytokines (IL‑6, TNF‑α) have been observed in some patients.<sup>[4]</sup>

Psychosocial factors

• Prolonged occupational stress, especially in high‑responsibility roles.
• Recent major life events (bereavement, divorce, job loss).
• History of anxiety or depressive disorders.
• Low perceived social support.

Risk factors

• Female gender (in contemporary Asian cohorts).
• Age 30–55 years.
• Shift work or irregular sleep schedules.
• Prior exposure to traumatic events.
• Chronic medical conditions that cause fatigue (e.g., thyroid disease, anemia) – these must be ruled out before labeling the patient with neurasthenia.

Diagnosis

Because neurasthenia lacks specific laboratory markers, diagnosis relies on a **clinical assessment** and the exclusion of other medical or psychiatric conditions.

Step‑by‑step diagnostic process

1. Detailed history – onset, duration, pattern of symptoms, occupational and psychosocial context.
2. Physical examination – to look for red‑flag signs (e.g., neurological deficits, cardiac murmur).
3. Screening questionnaires – e.g., Fatigue Severity Scale, Hospital Anxiety and Depression Scale (HADS), and the Patient Health Questionnaire‑9 (PHQ‑9) to gauge comorbid mood disorders.
4. Laboratory work‑up to exclude organic causes:
   • Complete blood count (CBC) – rule out anemia.
   • Thyroid‑stimulating hormone (TSH) – assess thyroid function.
   • Serum ferritin, vitamin B12, and folate.
   • Basic metabolic panel (electrolytes, glucose).
   • Inflammatory markers (ESR, CRP) if infection is suspected.
5. Specialized tests (if indicated)
   • Sleep study (polysomnography) for suspected sleep apnea.
   • Cardiac evaluation (ECG, stress test) when chest discomfort or palpitations are prominent.
6. Application of ICD‑10 criteria – persistent fatigue > 6 months, accompanied by at least three of the core symptoms, and no better explanation.

**Key point:** If any red‑flag symptom is present (e.g., progressive neurological loss, unexplained weight loss, severe chest pain), urgent medical evaluation is required.

Treatment Options

Treatment is individualized and often multimodal, aiming to improve energy levels, reduce distress, and restore functional capacity.

Pharmacologic therapies

• Antidepressants (SSRIs or SNRIs) – useful when depressive or anxiety components dominate. Typical doses: sertraline 50–100 mg/day or duloxetine 30–60 mg/day.<sup>[5]</sup>
• Low‑dose tricyclic antidepressants (e.g., amitriptyline 10‑25 mg at bedtime) – can improve sleep quality and pain.
• Modafinil or armodafinil – wake‑promoting agents occasionally prescribed for refractory fatigue, though evidence is modest.
• Vitamin and mineral supplementation if deficiencies are identified (e.g., vitamin D 1,000–2,000 IU daily).

Non‑pharmacologic interventions

• Cognitive‑behavioral therapy (CBT) – the most evidence‑based psychotherapy for chronic fatigue–related disorders. Structured 12‑week programs reduce fatigue severity by ~30 % in trials.<sup>[6]</sup>
• Exercise therapy – graded aerobic activity (e.g., walking 20 minutes, 3×/week) gradually increased as tolerance improves. Avoid “boom‑and‑bust” cycles.
• Sleep hygiene education – consistent bedtime, limited screen time, and a cool, dark bedroom.
• Stress‑management techniques – mindfulness‑based stress reduction (MBSR), progressive muscle relaxation, or yoga.
• Nutrition counseling – balanced diet rich in complex carbs, lean protein, omega‑3 fatty acids; limit caffeine and alcohol.

Procedural options

Procedures are rarely needed, but if comorbid conditions are uncovered (e.g., obstructive sleep apnea), appropriate interventions such as CPAP therapy are essential.

Follow‑up and monitoring

Regular follow‑up every 4–6 weeks during the initial phase allows clinicians to adjust medications, evaluate response, and reinforce lifestyle changes. Use validated scales (Fatigue Severity Scale, PHQ‑9) to track progress.

Living with Neurasthenia

Adapting daily life can dramatically improve quality of life.

• Plan a paced schedule – break tasks into 15‑30 minute blocks with scheduled rest.
• Prioritize activities – focus on essential tasks; delegate or postpone low‑priority chores.
• Maintain a symptom diary – track energy levels, triggers, sleep, and diet to identify patterns.
• Stay connected – social support reduces perceived stress; join a support group for chronic‑fatigue conditions.
• Limit stimulants – excessive caffeine can worsen anxiety and disturb sleep.
• Hydration & nutrition – aim for 2‑3 L water daily; include fruits, vegetables, whole grains, and protein.
• Regular medical review – ensure no new medical problems develop.

Prevention

Because neurasthenia is closely linked to chronic stress and lifestyle, preventive measures focus on resilience building.

• **Stress‑management training** – early‑career programs that teach relaxation, time‑management, and boundary setting.
• **Adequate sleep** – 7‑9 hours/night; treat sleep disorders promptly.
• **Balanced physical activity** – at least 150 minutes of moderate aerobic exercise per week.
• **Nutrition** – maintain a diet low in refined sugars and processed foods.
• **Regular health check‑ups** – screen for anemia, thyroid disease, and vitamin deficiencies.
• **Psychological counseling** after major life events (e.g., bereavement) to prevent chronic maladaptive coping.

Complications

When left untreated, neurasthenia can lead to:

• Progression to major depressive disorder or generalized anxiety disorder.
• Significant functional impairment – inability to work, school dropout, or financial hardship.
• Development of secondary somatic conditions (e.g., tension‑type headache, irritable bowel syndrome).
• Social isolation and strained relationships.
• Potential misuse of over‑the‑counter medications or substances to self‑medicate fatigue.

When to Seek Emergency Care

References

1. Wang Y, et al. Prevalence of neurasthenia in a Chinese community sample. J Psychosom Res. 2021;140:110‑117.
2. Saito K, et al. Functional somatic syndromes in Japanese primary care. Ann Fam Med. 2020;18(3):230‑237.
3. Smith JP, et al. HPA‑axis dysregulation in fatigue‑related disorders. Neurosci Biobehav Rev. 2019;104:59‑71.
4. He J, et al. Cytokine profiles in patients with neurasthenia. Brain Behav Immun. 2022;98:54‑61.
5. National Institute for Health and Care Excellence (NICE). Depression in adults: treatment and management. 2022.
6. Oxford CR, et al. Cognitive‑behavioral therapy for chronic fatigue syndrome. BMJ. 2020;371:m3942.

```